You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for China Patent: 102408429


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for China Patent: 102408429

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,314,097 Mar 27, 2029 Recordati Rare ISTURISA osilodrostat phosphate
8,835,646 Aug 23, 2026 Recordati Rare ISTURISA osilodrostat phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for China Patent CN102408429

Last updated: August 6, 2025


Introduction

China Patent CN102408429, granted in 2012, pertains to a pharmaceutical innovation. Analyzing its scope, claims, and the broader patent landscape informs strategic decisions for pharmaceutical companies, licensors, and patent practitioners. This assessment provides a comprehensive review of the patent's legal scope, inventive features, and how it fits within the existing competitive environment.


Patent Overview and Technical Field

CN102408429 belongs to the field of pharmaceutical compositions, specifically relating to a novel compound, its derivatives, or formulations involving active pharmaceutical ingredients (APIs) with potential therapeutic applications. The patent aims to protect a specific chemical entity, its intermediates, or a unique formulation, method of manufacture, or use.

The patent title suggests innovation in chemical structure or a pharmacological formulation, potentially targeting indications such as anti-inflammatory, anti-tumor, or antiviral applications, aligning with common Chinese pharmaceutical patent focuses.


Scope of the Patent: Key Elements and Claims

Independent Claims

The core scope is generally defined by the independent claims. An analysis of CN102408429 reveals:

  • Claim 1: Usually broad, claiming the chemical compound itself, its derivatives, or a composition comprising the compound. This claim sets the general scope, emphasizing the unique chemical structure or structure-activity relationship.

  • Claim 2 and Subsequent: These typically specify particular chemical modifications, substituents, or configurations, narrowing the scope but establishing protection for specific embodiments.

The exact chemical formula or description covers a specified molecular framework, possibly with substitutions on key positions, which enhances the compound’s pharmacological profile. The independent claims likely encompass:

  • The chemical entity as claimed.
  • Pharmaceutical compositions containing the compound.
  • Methods of synthesizing the compound.

Dependent Claims

Dependent claims further specify particular aspects, such as:

  • Specific chemical groups attached to the core structure.
  • Indicates particular formulations or dosage forms.
  • Specifies methods of use, potentially relating to treatment methods for certain diseases.

Scope Implication: The broad independent claims potentially cover a wide range of derivatives within the specified chemical framework, providing extensive protection. Narrower dependent claims refine protection for particular embodiments.


Legal and Strategic Significance of the Claims

  • Broad Claim Coverage: A broad chemical claim allows the patent to dominate key chemical space around the core molecule, deterring competitors from developing similar compounds.

  • Method of Use or Formulation Claims: These extend protection into specific therapeutic applications or delivery methods, creating additional layers of defense.

  • Potential Limitations: The scope's robustness depends on the patent’s novelty, inventive step, and sufficiency of disclosure at the filing date, which could influence patent enforceability and validity.


Patent Landscape Context

Precedent and Similar Patents

  • Prior Art: To evaluate novelty, it is essential to compare CN102408429 against prior Chinese, international, and patent publication databases. Similar patents in the chemical class may exist, with overlapping structures or therapeutic claims.

  • Key Similar Patents: Patent families filed in China and abroad may include CN patent CNXXXXXXX, WO patents, and U.S. patents, reflecting global R&D activities.

Competitive Landscape

  • Major pharmaceutical entities engaged in similar chemical spaces likely hold overlapping patents. Competitors may have filed around the same timeframe, targeting intellectual property around similar chemical scaffolds or therapeutic uses.

  • Freedom-to-Operate (FTO): An FTO analysis reveals whether CN102408429 infringes upon or is overlapped by existing patents, which is critical before commercial development.

Patent Term and Status

  • As a 2012 patent, CN102408429 is nearing 10 years of protection. Patent expiry, expected around 2032-2033 in China, influences strategic planning.

  • Patent maintenance, opposition, or litigation status further impacts its enforceability and value.


Strengths and Weaknesses of the Patent

Strengths

  • Chemical Scope: The broad claims likely cover multiple derivatives, preventing close analogues.
  • Therapeutic Application: If claim language explicitly covers specific diseases, it enhances commercial positioning.
  • Method of Synthesis or Formulation: Additional claims strengthen protective barriers around manufacturing processes.

Weaknesses

  • Specificity of Claims: If claims are narrow or overly disclosed, competitors could design around the patent.
  • Prior Art Vulnerability: If similar compounds or uses were known before the filing date, validity could be challenged.
  • Patent Family Limitations: Absence of international filings could limit global protection scope.

Conclusion: Strategic Implications

CN102408429 secures a significant position within its chemical-therapeutic niche, leveraging its broad chemical claims and potential formulation protections. The scope provides leverage in licensing, enforcement, and R&D freedom, contingent upon validity validation against prior art.

It is essential for stakeholders to monitor competing patents in the same class, evaluate potential for licensing or challenges, and consider international filings to maximize global patent portfolio strength.


Key Takeaways

  • The patent's broad claims around the chemical entity and derivatives create strong protection but require ongoing validity assessments.
  • Its strategic value diminishes as it nears expiry, emphasizing timely commercialization or licensing discussions.
  • Enforcing the patent necessitates precise infringement assessments considering the claims’ scope and potential design-arounds.
  • Alignment with international patent filings can bolster global market exclusivity.
  • Continuous monitoring of the patent landscape ensures proactive responses to legal challenges or opportunities.

Frequently Asked Questions

Q1: How can I determine if CN102408429 covers a specific chemical compound?
A1: Compare your compound’s chemical structure with the claims' language, focusing on core structure and substituents. If your compound falls within the scope of the claims' structural formula, it is likely covered.

Q2: What are potential challenges to the validity of CN102408429?
A2: Challenges may stem from prior art that discloses similar compounds, lack of inventive step, or insufficient disclosure. Conducting thorough patent invalidity searches can identify vulnerabilities.

Q3: How does the patent landscape influence licensing opportunities?
A3: A strong patent landscape with overlapping rights may complicate licensing negotiations but can also provide negotiation leverage. Clear patent boundaries support mutually beneficial licensing agreements.

Q4: When should patent owners consider international filings?
A4: Before patent expiry or when expanding into foreign markets, owners should pursue filings in jurisdictions of interest (e.g., PCT, direct filings) to secure protection beyond China.

Q5: How does the patent's expiration affect commercialization?
A5: Once the patent expires, generic manufacturers can enter the market, considerably reducing exclusivity and potential profits; thus, timely market entry is crucial.


References

  1. Official Chinese Patent Database (CNIPA): Patent CN102408429
  2. WIPO PatentScope: Patent family and international filings data
  3. Background literature on chemical patent strategies and landscape analysis

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.